Johnson & Johnson announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational study of icotrokinra, or JNJ-2113, the first targeted oral peptide that selectively blocks the ...
GlobalData on MSN3d
Johnson & Johnson MedTech announces partnership for soft tissue solutions"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback